Followers | 4049 |
Posts | 152440 |
Boards Moderated | 3 |
Alias Born | 08/05/2009 |
Wednesday, January 04, 2023 9:15:05 AM
Recent VVOS News
- Vivos Therapeutics Granted CPT® Coverage and Reimbursement Codes for All Vivos CARE Oral Medical Devices From American Medical Association • GlobeNewswire Inc. • 10/08/2024 11:30:00 AM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 09/24/2024 06:59:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2024 12:05:23 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/20/2024 12:00:29 PM
- Vivos Therapeutics Announces Pricing of $4.3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules • GlobeNewswire Inc. • 09/19/2024 11:00:00 AM
- Healthcare Shares Pop On FDA Clearance • AllPennyStocks.com • 09/18/2024 09:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2024 12:00:16 PM
- Vivos Therapeutics Receives Groundbreaking FDA 510(k) Clearance to Treat Moderate to Severe Pediatric Sleep Apnea and Snoring • GlobeNewswire Inc. • 09/18/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/17/2024 08:05:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/12/2024 09:00:13 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:24:05 PM
- Vivos Therapeutics Reports Second Quarter 2024 Financial Results and Provides Operational Update • GlobeNewswire Inc. • 08/14/2024 08:05:00 PM
- Vivos Therapeutics Schedules Release of Second Quarter 2024 Financial Results and Conference Call • GlobeNewswire Inc. • 08/14/2024 11:30:00 AM
- Form 424B1 - Prospectus [Rule 424(b)(1)] • Edgar (US Regulatory) • 08/08/2024 09:19:13 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 08/08/2024 04:15:19 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 07/30/2024 10:17:11 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2024 12:00:30 PM
- Vivos Therapeutics Announces Positive Results From 7-Month Multi-Site Pilot of its New Provider-Based Marketing and Distribution Model • GlobeNewswire Inc. • 06/27/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/14/2024 08:15:35 PM
- Vivos Therapeutics Closes $7.5 Million At-The-Market Private Equity-Backed Investment and Launches Strategic Marketing and Distribution Alliance • GlobeNewswire Inc. • 06/12/2024 11:30:00 AM
- Consolidated Water Comments on ISS and Glass Lewis Reports and Urges Stockholders to Vote “FOR” Re-Election of Its Highly Qualified Directors • GlobeNewswire Inc. • 05/20/2024 05:04:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:43:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 06:54:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 08:16:08 PM
- Vivos Therapeutics Reports First Quarter 2024 Financial Results and Provides Operational Update • GlobeNewswire Inc. • 05/14/2024 08:05:00 PM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM